Back
ALLETE, Inc. 10K Form
Buy
59
ALE
ALLETE, Inc.
Last Price:
$67.60
Seasonality Move:
3.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | ALE/ALLETE, Inc. Quarterly |
| 2024-02-20 | 10K | ALE/ALLETE, Inc. Annual |
| 2023-11-02 | 10Q | ALE/ALLETE, Inc. Quarterly |
| 2023-08-08 | 10Q | ALE/ALLETE, Inc. Quarterly |
| 2023-05-03 | 10Q | ALE/ALLETE, Inc. Quarterly |
| 2023-02-16 | 10K | ALE/ALLETE, Inc. Annual |
Receive ALE News And Ratings
See the #1 stock for the next 7 days that we like better than ALE
ALE Financial Statistics
Sales & Book Value
| Annual Sales: | $1.5B |
|---|---|
| Cash Flow: | $-174.2M |
| Price / Cash Flow: | 64.89 |
| Annual Sales: | $49.09 |
| Price / Book: | 1.38 |
Profitability
| EPS (TTM): | 2.85420 |
|---|---|
| Net Income (TTM): | $86.9M |
| Gross Margin: | $225.5M |
| Return on Equity: | 2.57% |
| Return on Assets: | 1.24% |
ALLETE, Inc. Earnings Forecast
Key ALLETE, Inc. Financial Ratios
-
The Gross Profit Margin over the past 45 years for ALE is 14.74%.
-
The Selling, General & Administrative Expenses for ALE have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 67.13% of Operating Income.
-
The Net Earning history of ALE is 7.96% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 19 years.
ALLETE, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Electric Utilities |
| Sector: | Utilities |
| Current Symbol: | ALE |
| CUSIP: | 018522 |
| Website: | allete.com |
Debt
| Debt-to-Equity Ratio: | 0.78 |
|---|---|
| Current Ratio: | 1.17 |
| Quick Ratio: | 0.55 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.79 |
|---|---|
| Forward P/E Ratio: | 16.57 |
ALE Technical Analysis vs Fundamental Analysis
Buy
59
ALLETE, Inc. (ALE)
is a Buy
Is ALLETE, Inc. a Buy or a Sell?
-
ALLETE, Inc. stock is rated a BuyThe current ALLETE, Inc. [ALE] share price is $67.60. The Score for ALE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.